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Abstract A biosustainable production route for 3-hydroxypropionic acid (3HP), an
important platform chemical, would allow 3HP to be produced without using fossil
fuels. We are interested in investigating a potential biochemical route to 3HP from
pyruvate through β -alanine and, in this paper, we develop and solve a mathematical
model for the reaction kinetics of the metabolites involved in this pathway. We con-
sider two limiting cases, one where the levels of pyruvate are never replenished, the
other where the levels of pyruvate are continuously replenished and thus kept con-
stant. We exploit the natural separation of both the time scales and the metabolite
concentrations to make significant asymptotic progress in understanding the system
without resorting to computationally expensive parameter sweeps. Using our asymp-
totic results, we are able to predict the most important reactions to maximize the
production of 3HP in this system while reducing the maximum amount of the toxic
intermediate compound malonic semialdehyde present at any one time, and thus we
are able to recommend which enzymes experimentalists should focus on manipulat-
ing.
Keywords Asymptotic analysis · Reaction kinetics · Synthetic biology · Metabolic
pathways
1 Introduction
3-hydroxypropionic acid (3HP) can be used to produce many other valuable chemi-
cals, such as acrylic acid, 1,3-propanediol, and biodegradable polyesters (Werpy et al.
2004; Jiang et al. 2009). 3HP can be derived from biological sources and, as current
industrial methods to produce acrylic acid involve fossil fuels, a production route
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through 3HP provides a biosustainable alternative. Although an in vivo production
line in a bacterial or fungal host is the eventual industrial target for 3HP, perform-
ing in vitro experiments is an important prior step. The controlled nature of in vitro
experiments allows for more systematic deductions to be made, and hence in vitro
experiments can highlight potential roadblocks that may be more difficult to analyse
in a complex in vivo system. Mathematical modelling allows for further systematic
progress to be made, and can reduce the experimental parameter space that needs to
be searched.
In Kumar et al. (2013), three thermodynamically feasible pathways from pyru-
vate to 3HP are suggested. We are interested here in mathematically modelling the
route through aspartate and β -alanine; this is the synthetic pathway successfully in-
troduced to Saccharomyces cerevisiae in Borodina et al. (2015). Thus, we consider
the reactions
Pyruvate
k1−−→ Oxaloacetate, (1a)
Oxaloacetate+GLU
k2−−→ AKG+Aspartate, (1b)
Aspartate+PAND
k3−−⇀↽−
k−3
PANDc
k4−−→ β -alanine+PAND, (1c)
β -alanine+Pyruvate+BAPAT
k5−−⇀↽−
k−5
BAPATc
k6−−→ L-alanine+BAPAT
+Malonic semialdehyde, (1d)
L-alanine+AKG+ALT
k7−−⇀↽−
k−7
ALTc
k8−−⇀↽−
k−8
Pyruvate+GLU+ALT, (1e)
Malonic semialdehyde+HPDH
k9−−⇀↽−
k−9
HPDHc
k10−−→ 3HP+HPDH, (1f)
and we show a schematic representation of this pathway in figure 1.
Here, we do not consider enzymemechanics for the first two reactions in (1). This
is because pyruvate and oxaloacetate are required for the citric acid cycle, and we are
not interested in altering any enzymatic processes that may significantly change this
important metabolic cycle. Thus, the enzyme kinetics for the latter four reactions are
the most appropriate targets for enhancement, and we therefore include these.
We note that (1e), the reaction between L-alanine and pyruvate, is not neces-
sary for a connected pathway between pyruvate and 3HP. However, as (1e) recycles
L-alanine and α-ketoglutarate (AKG) back into pyruvate and glutamic acid (GLU),
used in (1a) and (1b), respectively, the inclusion of (1e) may enhance the efficiency
of the pathway. In Borodina et al. (2015), it was hypothesized that (1e) may have an
effect on the overall 3HP production, and we investigate this hypothesis here. More
generally, we are interested in determining which of the reactions are the most impor-
tant for 3HP production. Additionally, malonic semialdehyde is a toxic compound,
and so we will also look for ways to reduce the amount of malonic semialdehyde
present in the system. To summarize, the general goal of this system, so far as pos-
sible, is to maximize the 3HP produced whilst minimizing the maximum level of
malonic semialdehyde present in the system.
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Pyruvate ([S1])
Oxaloacetate ([S2]) Aspartate ([S3])
β-alanine ([S4])
L-alanine ([S5]) Malonic semialdehyde ([S6])
3HP ([P ])
PAND ([E1])
BAPAT ([E2])
HPDH ([E3])
ALT ([E4])
Fig. 1 A schematic network diagram for the pathway we consider in this paper, where arrows denote the
direction of the reactions. The dashed lines denote reactions which additionally require GLU ([R1]) and
produce AKG ([R2]), and the dotted lines denote reactions which additionally require AKG and produce
GLU. If we consider the enzyme mechanics for a reaction, we include the name of that enzyme next to the
reaction arrow.
We will assume that there are enough molecules of each metabolite to use the
law of mass action and that the entire system is well-mixed and thus spatially in-
dependent. Moreover, in any given reaction, we neglect any inhibitory effects from
metabolites not involved in the reaction and from any products of the reaction. We do
so to limit the number of parameters in the model, and to enable us to make analytic
progress, thus allowing us to develop physical insight into the system. Additionally,
the production levels of pyruvate within the system will vary in time. We consider
two limiting cases, pyruvate being a finite resource which is never replenished in the
first, but an infinite resource held at a constant concentration in the second. Whilst the
actual levels of pyruvate will, in practice, fall somewhere between these two cases, it
is useful to analyse both in detail: exploring and comparing these two extreme cases
will provide insight into the general pathway kinetics in intermediate cases.
As there are many parameters involved in this problem, a fully experimental ap-
proach would be very time consuming. For the same reason, investigating its mathe-
matical model using a purely numerical approach would also be a protracted process,
albeit shorter than the fully experimental one. We perform an asymptotic analysis
(see, for example, Kevorkian and Cole (2013); Hinch (1991); O’Malley, Jr. (2012))
to investigate our model, thus enhancing our physical insight into the underlying sys-
tem and enabling us to determine how the concentrations vary as functions of the
experimental parameters. Due to this approach, exact knowledge of each kinetic pa-
rameter is not required, just an estimate of the order of magnitude of each parameter.
We introduce a mathematical model to describe the nonlinear reaction kinetics in
§2.We solve this for non-replenished and continuously replenished pyruvate in §3 and
§4, respectively, where we give both numerical and asymptotic solutions to describe
the system behaviour. We also consider the problem of general pyruvate production
in Appendix C, where we derive asymptotic solutions in one time regime for the
metabolite concentrations at leading order in terms of the pyruvate in the system. We
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finish by discussing our results and comparing the two regimes in §5, where we also
suggest future avenues of inquiry that follow from this work.
2 Model description
We assume that the reaction kinetics are governed by the law of mass action, yielding
the system
d[S1]
dτ
=−k1[S1]− k5[S1][S4][E2]+ k−5[C2]+ k8[C4]− k−8[S1][R1][E4], (2a)
d[S2]
dτ
= k1[S1]− k2[S2][R1], (2b)
d[S3]
dτ
= k2[S2][R1]− k3[S3][E1]+ k−3[C1], (2c)
d[S4]
dτ
= k4[C1]− k5[S4][S1][E2]+ k−5[C2], (2d)
d[S5]
dτ
= k6[C2]− k7[S5][R2][E4]+ k−7[C4], (2e)
d[S6]
dτ
= k6[C2]− k9[S6][E3]+ k−9[C3], (2f)
d[R1]
dτ
=−k2[S2][R1]+ k8[C4]− k−8[S1][R1][E4], (2g)
d[R2]
dτ
= k2[S2][R1]− k7[S5][R2][E4]+ k−7[C4], (2h)
d[E1]
dτ
=−k3[S3][E1]+ k−3[C1]+ k4[C1], (2i)
d[E2]
dτ
=−k5[S4][S1][E2]+ k−5[C2]+ k6[C2], (2j)
d[E3]
dτ
=−k9[S6][E3]+ k−9[C3]+ k10[C3], (2k)
d[E4]
dτ
=−k7[S5][R2][E4]+ k−7[C4]+ k8[C4]− k−8[S1][R1][E4], (2l)
d[C1]
dτ
= k3[S3][E1]− k−3[C1]− k4[C1], (2m)
d[C2]
dτ
= k5[S4][S1][E2]− k−5[C2]− k6[C2], (2n)
d[C3]
dτ
= k9[S6][E3]− k−9[C3]− k10[C3], (2o)
d[C4]
dτ
= k7[S5][R2][E4]− k−7[C4]− k8[C4]+ k−8[S1][R1][E4], (2p)
d[P]
dτ
= k10[C3]. (2q)
All the variables introduced here are defined in table 1, and the units and typical val-
ues for each kinetic parameter are given in table 2. We model a scenario where each
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Original
variable Description Nondimensionalisation
[S1] Pyruvate [S1] = S0S1
[S2] Oxaloacetate [S2] = S0S2
[S3] Aspartate [S3] = εS0S3
[S4] β -alanine [S4] = εS0S4
[S5] L-alanine [S5] = εS0S5
[S6] Malonic semialdehyde [S6] = ε
4S0S6
[R1] Glutamic acid (GLU) [R1] = S0R1
[R2] α-ketoglutarate (AKG) [R2] = εS0R2
[E1] Aspartate decarboxylase (PAND) [E1] = εa1S0E1
[E2] β -alanine-pyruvate aminotransferase (BAPAT) [E2] = εa2S0E2
[E3] 3-hydroxypropionate dehydrogenase (HPDH) [E3] = εa3S0E3
[E4] Alanine aminotransferase (ALT) [E4] = εa4S0E4
[C1] Aspartate decarboxylase complex (PANDc) [C1] = ε
2a1S0C1
[C2] β -alanine-pyruvate aminotransferase complex (BAPATc) [C2] = ε
4a2S0C2
[C3] 3-hydroxypropionate dehydrogenase complex (HPDHc) [C3] = ε
5a3S0C3
[C4] Alanine aminotransferase complex (ALTc) [C4] = ε
3a4S0C4
[P] 3-hydroxypropionic acid (3HP) [P] = ε3S0P
τ Time τ = t/k1
Table 1 Dimensional and dimensionless variable definitions. The dimensional metabolite concentrations
are denoted with square brackets and have units of moles per volume, as does S0 .
of the enzymes are introduced to a solution containing only pyruvate and glutamic
acid, and this resulting mixture is instantaneously well-mixed. We assume that the
initial concentration of pyruvate is [S1](0) = S0, where S0 is around 1mM. We will
state the remaining initial conditions after discussing how we deal with uncertainty
in the kinetic parameters.
We see in table 2 that estimates for the kinetic parameters can vary over three
orders of magnitude between different organisms. To investigate how the system be-
haves as these parameters vary we first form dimensionless variables, scaling each
dimensional metabolite concentration with S0 and time with 1/k1 (the characteris-
tic time of the first reaction between pyruvate and oxaloacetate). Moreover, we form
dimensionless parameters by scaling the kinetic parameters with k1 and the appro-
priate power of S0. We then introduce the artificial small dimensionless parameter
ε = 10−2, and allow each dimensionless system parameter to be written as cε j where
c is an O(1) parameter (between 0.1 and 10), and j is an integer. The dimensionless
parameters in our system are given in the lower half of table 2. This approach al-
lows us to interrogate the system using an asymptotic analysis. Although (as always)
there may theoretically be an issue with this method in equating terms with the same
powers of ε when large (or small) O(1) parameters are multiplied together, we will
show that our asymptotic and numerical results show excellent agreement, and thus
the approach is reliable for this system.
For the initial conditions, we assume that the initial levels of pyruvate and of glu-
tamic acid are of comparable size and, to mimic the environment within a cell, that
these concentrations are much larger than the initial concentrations of each enzyme.
Additionally, we assume that the initial concentrations of each enzyme are of com-
parable size. Although enzyme-to-substrate levels will vary, a reasonable assump-
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Dimensional parameter Organism Parameter range
k1 = 10
−2 s−1 Saccharomyces cerevisiaea 8×10−3 – 2×10−1 s−1 a,g
k2 = 7×10−5mM−1s−1 Thermus thermophilusb 7×10−5 – 1×10−3mM−1s−1 b,h
k3 = 10
2mM−1s−1 Escherichia colic 1×101 – 1.6×103mM−1s−1 c,i, j
k−3 = 2×101 s−1 Escherichia colic 1×100 – 2×102 s−1 c,i, j
k4 = 1s
−1 Escherichia colic 2×10−1 – 2×101 s−1 c,i, j
k5 = 4×10−2mM−2s−1 Bacillus cereusd 7×10−3 – 2×10−1mM−2s−1 d,k
k−5 = 80s−1 Bacillus cereusd 1×101 – 5×102 s−1 d,k
k6 = 1.5s
−1 Bacillus cereusd 1×100 – 4×100 s−1 d,k
k7 = 3×10−2mM−2s−1 Pyrococcus furiosuse 1×10−2 – 2×100mM−2s−1 e,l
k−7 = 102 s−1 Pyrococcus furiosuse 5×100 – 6×102 s−1 e,l
k8 = 10
2 s−1 Pyrococcus furiosuse 5×100 – 6×102 s−1 e,l
k−8 = 4×10−2mM−2s−1 Pyrococcus furiosuse 1×10−2 – 1×100mM−2s−1 e,l
k9 = 10
2mM−1s−1 Metallosphaera sedula f 5×101 – 2×102mM−1s−1 f
k−9 = 5s−1 Metallosphaera sedula f 1×100 – 1×101 s−1 f
k10 = 30s
−1 Metallosphaera sedula f 1×100 – 1×102 s−1 f ,m
Dimensionless parameter
k¯2 = k2S0/(εk1) = 0.7
k¯3 = k3a1S0ε
2/k1 = a1
k¯−3 = k−3a1ε2/k1 = 0.2a1
k¯4 = k4a1ε/k1 = a1
k¯5 = k5a2S
2
0/k1 = 4a2
k¯−5 = k−5a2ε2/k1 = 0.8a2
k¯6 = k6a2ε/k1 = 1.5a2
k¯7 = k7a4S
2
0/k1 = 3a4
k¯−7 = k−7a4ε2/k1 = a4
k¯8 = k8a4ε
2/k1 = a4
k¯−8 = k−8a4S20/k1 = 4a4
k¯9 = k9a3S0ε
2/k1 = a3
k¯−9 = k−9a3ε/k1 = 5a3
k¯10 = k10a3ε
2/k1 = 0.3a3
Table 2 Kinetic reaction rate parameters. In general, it is only ratios of kinetic parameters that are known
for a given reaction, as substrate binding to an enzyme is too quick to accurately measure the reaction rate.
We therefore choose parameter values (using the ratios given in the references) that lead to the enzyme
complexes being formed over a time period that is much shorter than the time period over which the
metabolite concentrations change. This, experimental uncertainty, and differences in enzymes in different
organisms lead to a large possible range for the parameter values. In scaling the kinetic parameters with S0
and powers of ε , we have used the values S0 = 1mM, ε = 10
−2. The values of k1 and k2 are chosen to be
effective reaction rates as we are not interested in modifying native enzymes. Thus, k1 is the ratio of the
PYC turnover number to the Michaelis constant for pyruvate multiplied by an estimated concentration of
PYC, chosen to be around 1µM. k2 is the ratio of the AAT turnover number to the product of the Michaelis
constants for oxaloacetate and GLU, multiplied by an estimated concentration of AAT, chosen to be around
0.1µM. The references are: a Branson et al. (2002), b Nobe et al. (1998), c Ramjee et al. (1997) , d Nakano
et al. (1977), e Ward et al. (2000), f Kockelkorn and Fuchs (2009), g Jitrapakdee et al. (2007), h Yagi et al.
(1982), i Chopra et al. (2002), j Williamson and Brown (1979), k Hayaishi et al. (1961), l Umemura et al.
(1994), m Berg et al. (2007).
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tion is that this ratio is around 1:100 and thus of O(ε) for our problem (Albe et al.
1990). Thus, recalling that [S1](0) = S0, we also have [R1](0) =αS0, [E1](0) = εa1S0,
[E2](0) = εa2S0, [E3](0) = εa3S0, and [E4](0) = εa4S0, noting that the remaining
metabolite concentrations start at zero. The dimensionless parameters α , a1, a2, a3,
and a4 are of O(1). These conditions will allow us to investigate how the system
changes as the initial conditions of the system vary when we perform our asymptotic
analysis. From the initial conditions and (2i)–(2p), we can immediately deduce that
[Ei]+ [Ci] = [Ei](0), (3)
where i = 1,2,3,4.
As we now have our dimensionless variables in terms of powers of ε , we can
scale each concentration variable with the appropriate power of ε to obtain the cor-
rect leading-order system for t = O(1). This will allow us to immediately perform an
asymptotic analysis for small ε . We give the correct scalings for these variables in
table 1, obtained by considering a dominant balance for each equation in the system
and the non-zero initial conditions discussed above. We will perform a similar proce-
dure to determine the correct asymptotic scalings over longer timescales, for which
we will use effective ‘initial’ conditions obtained by asymptotic matching between
timescales. The dimensionless form of (3) yields the relationships E1 = 1− εC1,
E2 = 1− ε3C2, E3 = 1− ε4C3, and E4 = 1− ε2C4. Replacing each instance of Ei
(for i ∈ {1,2,3,4}) with the appropriate function ofCi allows us to reduce the dimen-
sion of the system of ODEs, accounting for (2i)–(2l). The remaining dimensionless
system is
S˙1 =−S1− ε2k¯5S1S4
(
1− ε3C2
)
+ ε2k¯−5C2+ ε k¯8C4− ε k¯−8S1R1
(
1− ε2C4
)
,
(4a)
S˙2 = S1− ε k¯2S2R1, (4b)
ε S˙3 = ε k¯2S2R1− k¯3S3 (1− εC1)+ k¯−3C1, (4c)
S˙4 = k¯4C1− ε k¯5S1S4
(
1− ε3C2
)
+ ε k¯−5C2, (4d)
S˙5 = ε
2k¯6C2− ε2k¯7S5R2
(
1− ε2C4
)
+ k¯−7C4, (4e)
ε S˙6 = k¯6C2− k¯9S6
(
1− ε4C3
)
+ ε k¯−9C3, (4f)
R˙1 =−ε k¯2S2R1+ ε k¯8C4− ε k¯−8S1R1
(
1− ε2C4
)
, (4g)
R˙2 = k¯2S2R1− ε2k¯7S5R2
(
1− ε2C4
)
+ k¯−7C4, (4h)
ε2C˙1 = k¯3S3 (1− εC1)− k¯−3C1− ε k¯4C1, (4i)
ε2a2C˙2 = k¯5S1S4
(
1− ε3C2
)− k¯−5C2− ε k¯6C2, (4j)
ε2a3C˙3 = k¯9S6
(
1− ε4C3
)− ε k¯−9C3− k¯10C3, (4k)
ε2a4C˙4 = ε
2k¯7S5R2
(
1− ε2C4
)− k¯−7C4− k¯8C4+ k¯−8S1R1 (1− ε2C4) , (4l)
P˙ = k¯10C3, (4m)
where the dimensionless parameters are defined in table 2 and an overdot denotes
d/dt. In the following two sections, we solve the system presented in (4) for non-
replenished and constantly replenished pyruvate, respectively. The non-replenished
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case is governed by (4), and the replenished case by (4b–m), with (4a) replaced by
S1 ≡ 1. For future reference, we note the immediate consequence of (4c) and (4i),
that
S˙3+ εC˙1 = k¯2S2R1− k¯4C1, (5)
which is a statement about the evolution of aspartate from oxaloacetate and towards
PANDc - (5) follows on dividing the sum of (4c) and (4i) by ε , and will furnish an
additional leading-order equation in the limit ε → 0, in which (4c) and (4i) as they
stand lead to a duplication of information.
3 Non-replenished pyruvate
3.1 Numerical results
We solve the system (4) numerically, using ode15s in MATLAB. Our asymptotic
solutions will reveal that the system is stiff, and our choice of numerical approach
reflects this. We use the parameter values given in table 2, and see that there are
two important timescales, where t = O(1) and t = O(1/ε) (recalling that ε = 10−2),
respectively (figure 2). Over each of these timescales, the levels of malonic semialde-
hyde rise then fall, and the levels of 3HP rise to a plateau. Additionally, the levels
of malonic semialdehyde and 3HP can vary significantly when the initial concen-
tration of different enzymes is increased (over-expression). We model the effect of
over-expressing a particular enzyme by starting the simulation with twice the levels
of that enzyme compared to the black reference line in figure 2. We emphasize that
the parameter values we give are not likely to be exact but, as we will later derive
solutions to our system as functions of these parameters, we will be able to determine
which reactions are the most important to the system by analyzing the form of these
solutions without knowledge of the exact values that these parameters take.
We now discuss how the over-expression of a given enzyme affects the system.
A schematic for the metabolic network is given in figure 1. Increasing the levels of
PAND has a positive but small effect on the levels of both malonic semialdehyde and
3HP. Over-expressing BAPAT has a much larger effect, significantly increasing the
levels of both malonic semialdehyde and 3HP. In contrast, we see that over-expressing
HPDH does not appear to have any effect on the levels of 3HP and, in fact, signif-
icantly decreases the maximum amount of malonic semialdehyde in the system. Fi-
nally, we see that over-expressing ALT has a very small negative effect on the levels
of malonic semialdehyde, and a significant positive effect on the levels of 3HP.
In the next section, we explore the system (4) using an asymptotic analysis. This
will allow us to determine how the system depends on the dimensionless parameters,
and thus to explore the experimental parameter space without resorting to computa-
tionally expensive parameter sweeps.
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Fig. 2 Numerical solutions in the non-replenished pyruvate case for the dynamic concentrations of (a)
malonic semialdehyde and (b) 3HP. We use the parameter values given in table 2 for all simulations,
and initial dimensionless enzyme concentrations of 1 unless specified in the legend. The solid black line
corresponds to the reference simulation where ai = 1 for i = 1,2,3,4.
3.2 Asymptotic structure
We now investigate the system (4) by exploiting the small parameter, ε , using an
asymptotic analysis. There are two main asymptotic regions of interest in time, where
t = O(1) and t = O(1/ε), which we refer to as medium and long time, respectively
(figure 2).
When t = O(1), the system is governed by the release of pyruvate and GLU
through the main pathway to 3HP and towards the production of L-alanine. When
t =O(1/ε), the levels of pyruvate have diminished, and the system is governed by the
degradation of oxaloacetate with GLU into aspartate and AKG. Additionally, the L-
alanine producedwhen t =O(1) is now converted back into pyruvate which, although
only a small amount, is enough to have a leading-order effect on the reaction with β -
alanine, and thus a leading-order effect on the amount of 3HP produced. Thus, the L-
alanine acts as a store of pyruvate over t =O(1), and this is released over t = O(1/ε).
In the next section, we solve the leading-order versions of the system (4) in each of
these asymptotic regions.
3.3 Asymptotic solutions
The early-time behaviour of the system is given in Appendix A, obtained by Taylor
expanding the initial conditions as t → 0+. The more interesting behaviour for mal-
onic semialdehyde and 3HP production occurs for medium and long time, and we
now consider the system dynamics over these timescales in turn.
3.3.1 Medium time: t = O(1)
As ε → 0, the full system (4) becomes the differential-algebraic system
S˙1 =−S1, S˙2 = S1, S˙3 = k¯2S2R1− k¯4C1, S˙4 = k¯4C1, S˙5 = k¯−7C4,
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R˙1 = 0, R˙2 = k¯2S2R1+ k¯−7C4, P˙ = k¯10C3, (6a)
k¯9S6 = k¯6C2, k¯−3C1 = k¯3S3, k¯−5C2 = k¯5S1S4, k¯10C3 = k¯9S6,(
k¯−7+ k¯8
)
C4 = k¯−8S1R1, (6b)
on using (5).
We solve the leading-order system (6) explicitly as ε → 0, and the solutions are
given by
S1 = e
−t , (7a)
S2 = 1− e−t, (7b)
S3 = β3
(
1− ωe
−t − e−ωt
ω− 1
)
, (7c)
S4 = β4
(
t +
ω2e−t − e−ωt + 1−ω2
ω(ω − 1)
)
, (7d)
S5 = β5
(
1− e−t) , (7e)
S6 = β6
(
t +
ω2e−t − e−ωt + 1−ω2
ω(ω − 1)
)
e−t , (7f)
R1 = α, (7g)
R2 = β4
(
t + e−t − 1)+β5 (1− e−t) , (7h)
C1 = γ1
(
1− ωe
−t − e−ωt
ω− 1
)
, (7i)
C2 = γ2
(
t +
ω2e−t − e−ωt + 1−ω2
ω(ω− 1)
)
e−t , (7j)
C3 = γ3
(
t +
ω2e−t − e−ωt + 1−ω2
ω(ω− 1)
)
e−t , (7k)
C4 = γ4e
−t , (7l)
P = λ
((
e−ωt
ω (ω2− 1) − t +
1
ω
− ωe
−t
2(ω − 1)
)
e−t +
ω
2(ω + 1)
)
, (7m)
where we define the parameters
β3 = α k¯2/ω , β4 = α k¯2, β5 = α k¯−7k¯−8/(k¯−7+ k¯8), β6 = α k¯2k¯5k¯6/(k¯−5k¯9),
γ1 = α k¯2/k¯4, γ2 = α k¯2k¯5/k¯−5, γ3 = α k¯2k¯5k¯6/(k¯−5k¯10),
γ4 = α k¯−8/(k¯−7+ k¯8),λ = α k¯2k¯5k¯6/k¯−5, ω = k¯3k¯4/k¯−3. (8)
From table 2, we see that the parameter ω = k¯3k¯4/k¯−3 is associated with (1c), the
reaction from aspartate to β -alanine. That is, ω is proportional to both the ratio of the
forward to backward reaction rate constants in (1c) and to the initial concentration of
PAND, the enzyme that controls (1c). Thus, from the prevalence of ω in the solution
(7), we see that (1c) affects the timing of the system when t = O(1), and the other
reactions control the concentration levels of the metabolites. For later analysis, we
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Fig. 3 The numerical and asymptotic solutions for the metabolite concentrations in the non-replenished
pyruvate case. The solid light lines denote the numerical solutions, and the broken darker lines denote the
asymptotic solutions. Dashed lines represent the t =O(1) solutions given in (7), dash-dotted lines represent
the early-time solutions given in Appendix A, and dotted lines represent the late time solutions given in
(11), (B2), and (B4). We use parameter values α = 0.5, a1 = 1, a2 = 1, a3 = 1, and a4 = 1. We have split
the metabolite concentrations into (a) the substrates that tend to a non-zero constant value for large time,
(b) the substrates which tend to zero for large time, (c) the enzyme complexes, and (d) the product. We
plot ([Si], [Ri], [Ci ], [P])/S0 .
additionally note that the parameter grouping k¯5k¯6/k¯−5 is associated with (1d), the
reaction from β -alanine and pyruvate to L-alanine and malonic semialdehyde.
We note there is an implicit assumption that ω 6= 1 in writing (7), but the ap-
parent singularities are removable in this limit and, as such, they do not change the
nature of the solutions. We see that these solutions are excellent approximations to
the numerical solutions (dashed lines in figure 3).
Whilst the solutions (7) do satisfy the given initial conditions, several were not
formally imposed in the solution derivation. This is because the system (4) is singular
as ε → 0. Although we could do this formally by matching the solution (7) with an
early-time solution, it is simpler to Taylor expand the initial conditions as t → 0+.
We do this in Appendix A. We see that these solutions are excellent approximations
to the numerical solutions (dash-dotted lines in figure 3).
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3.3.2 Late time: t = O(1/ε)
The more interesting behaviour occurs for longer time. The solutions for S4 and R2,
given in (7d) and (7h), respectively, appear to be unbounded. As we start with a
finite level of nonreplenishable pyruvate, this is unphysical and suggests that there are
further dynamics at play. We can obtain the correct scaling by looking for a change in
leading-order terms in the system (4), which occurs when t = O(1/ε). To investigate
this, we introduce t = T/ε , where T = O(1), and we make the asymptotic scalings
(S4,R2) = ε
−1(S4,R2), (S6,C2,C3,C4) = ε(S6,C2,C3,C4), and S1 = ε2S1. The long-
term version of the system (4) is
ε
dS1
dT
=−S1− ε k¯5S1S4
(
1− ε4C2
)
+ ε k¯−5C2+ k¯8C4+ ε k¯−8S1R1
(
1− ε3C4
)
,
(9a)
dS2
dT
= εS1− k¯2S2R1, (9b)
ε2
dS3
dT
= ε k¯2S2R1− k¯3S3
(
1− ε2C1
)
+ k¯−3C1, (9c)
dS4
dT
= k¯4C1− ε2k¯5S1S4
(
1− ε4C2
)
+ ε2k¯−5C2, (9d)
dS5
dT
= ε2k¯6C2− k¯7S5R2
(
1− ε3C4
)
+ k¯−7C4, (9e)
ε2
dS6
dT
= k¯6C2− k¯9S6
(
1− ε5C3
)
+ ε k¯−9C3, (9f)
dR1
dT
=−k¯2S2R1+ ε k¯8C4− ε2k¯−8S1R1
(
1− ε3C4
)
, (9g)
dR2
dT
= k¯2S2R1− ε k¯7S5R2
(
1− ε3C4
)
+ ε k¯−7C4, (9h)
ε3
dC1
dT
= k¯3S3
(
1− ε2C1
)− k¯−3C1− ε k¯4C1, (9i)
ε3a2
dC2
dT
= k¯5S1S4
(
1− ε4C2
)− k¯−5C2− ε k¯6C2, (9j)
ε3a3
dC3
dT
= k¯9S6
(
1− ε5C3
)
− ε k¯−9C3− k¯10C3, (9k)
ε3a4
dC4
dT
= k¯7S5R2
(
1− ε3C4
)− k¯−7C4− k¯8C4+ ε k¯−8S1R1 (1− ε3C4) , (9l)
dP
dT
= k¯10C3, (9m)
and (5) becomes
ε
dS3
dT
+ ε2
dC1
dT
= k¯2S2R1− k¯4C1. (9n)
The leading-order version of (9) is the differential-algebraic system
dS2
dT
=−k¯2S2R1, dS4
dT
= k¯4C1,
dS5
dT
=−k¯7S5R2+ k¯−7C4, dR1
dT
=−k¯2S2R1,
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dR2
dT
= k¯2S2R1,
dP
dT
= k¯10C3, (10a)
S1 = k¯8C4, k¯3S3 = k¯−3C1, k¯9S6 = k¯6C2, k¯4C1 = k¯2S2R1, k¯−5C2 = k¯5S1S4,
k¯10C3 = k¯9S6,
(
k¯−7+ k¯8
)
C4 = k¯7S5R2. (10b)
Now the system is controlled by the nonlinear dynamics of S2 and R1, and the
solutions to the leading-order system (10) are
S1 = β4β5Ω
ek¯2(α−1)T − 1
αek¯2(α−1)T − 1
(
e−α k¯2T −αe−k¯2T
1−α
)Ω
, (11a)
S2 =
α− 1
αek¯2(α−1)T − 1 , (11b)
S3 = β3(α − 1)2 e
k¯2(α−1)T
(αek¯2(α−1)T − 1)2 , (11c)
S4 = α
ek¯2(α−1)T − 1
αek¯2(α−1)T − 1 , (11d)
S5 = β5
(
e−α k¯2T −αe−k¯2T
1−α
)Ω
, (11e)
S6 = αβ5β6Ω
(
ek¯2(α−1)T − 1
αek¯2(α−1)T − 1
)2(
e−α k¯2T −αe−k¯2T
1−α
)Ω
, (11f)
R1 = α(α − 1) e
k¯2(α−1)T
αek¯2(α−1)T − 1 , (11g)
R2 = α
ek¯2(α−1)T − 1
αek¯2(α−1)T − 1 , (11h)
C1 = γ1(α − 1)2 e
k¯2(α−1)T
(αek¯2(α−1)T − 1)2 , (11i)
C2 = αβ5β6γ2Ω
(
ek¯2(α−1)T − 1
αek¯2(α−1)T − 1
)2(
e−α k¯2T −αe−k¯2T
1−α
)Ω
, (11j)
C3 = αβ5γ3Ω
(
ek¯2(α−1)T − 1
αek¯2(α−1)T − 1
)2(
e−α k¯2T −αe−k¯2T
1−α
)Ω
, (11k)
C4 = β4β5Ω
ek¯2(α−1)T − 1
αek¯2(α−1)T − 1
(
e−α k¯2T −αe−k¯2T
1−α
)Ω
, (11l)
P =
λ ω
2(ω + 1)
+
αβ5λ Ω
k¯2 (1−α)Ω
∫ k¯2T
0
(
e−αs− e−s)2 (e−αs−αe−s)Ω−2 ds, (11m)
where Ω = k¯7k¯8/(k¯2(k¯−7+ k¯8)), which is proportional to the initial concentration of
ALT, the enzyme controlling (1e). Thus, Ω is associated with the reversible reaction
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between L-alanine and pyruvate, and terms that are raised to the power of Ω arise due
to this reaction. In contrast, the terms not raised to the power of Ω in the integrand of
(11m) arise due to the conversion of pyruvate into β -alanine.
To match the long-term solutions (11) with the t = O(1) solutions (7), we would
have to consider intermediate matching regionswhere exponentially decreasing terms
balance algebraically growing terms. These regions occur between t = O(1) and t =
O(1/ε), and thus generally involve a translation in time of somemultiple of log(1/ε).
As these regions are uninteresting - the decreasing and increasing terms pass by each
other without interacting - we omit further discussion of these regions.
The long-time dynamics described by (11) are sensitive to the sign of α−1, with
the singularities as α → 1 being removable. Moreover, the steady states in (11) as
T → ∞ depend on the sign of α − 1, and thus are sensitive to the initial ratio of
pyruvate to GLU. The exponential decay to these steady states slows down as α → 1,
and becomes algebraic decay in the limit.
There is further long-time behaviour that can occur in this system, though only
for certain parameter regimes. We discuss this behaviour in Appendix B.1.
3.4 Discussion
Of the reactions given in (1), (1c–f) are heterologous in Saccharomyces cerevisiae
(that is, they are not native to the microorganism), and are the most appropriate targets
for enhancement. Thus, identifying and enabling the correct enzymes within cells for
these reactions is paramount. To this end, we discuss our results in the context of
being able to vary parameters from reactions (1c–f).
The general goal of the metabolic system we have considered is to maximise the
total 3HP produced, whilst minimizing the malonic semialdehyde (S6) produced, as
the latter is toxic. The total 3HP produced at leading order, Ptot, can be obtained by
taking the limit as t → ∞ in (7m), and is given by
Ptot = λ
(
ω
2(ω + 1)
+
β5
k¯2
I(α,Ω)
)
, (12a)
I(α,Ω) =
αΩ
(1−α)Ω
∫ ∞
0
(
e−αs− e−s)2 (e−αs−αe−s)Ω−2 ds. (12b)
The integral (12b) has asymptotic behaviour I ∼ 1 as α → 0, I ∼ 1/α as α →∞, I ∼ 1
as Ω → 0 for α < 1, I ∼ 1/α as Ω → 0 for α > 1, and I ∼
√
pi/(2αΩ) as Ω → ∞,
which agree well with the numerical solutions of (12b) (figure 4). To numerically
evaluate (12b), we make the substitution u = e−s to switch to a finite domain and use
an asymptotic approximation to evaluate the integral near u = 0, where the integrand
has an integrable singularity.
The amount of S6 present in the system is at its maximum when t = O(1), and we
give an analytic expression for this in (7f), from which we see that
max
t>0
S6(t) = β6 f (ω ;u(ω)), (13a)
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Fig. 4 The function I(α ,Ω ) defined in (12b). (a) Constant Ω and varying α . (b) Constant α and varying
Ω . The solid curves are the numerically derived values, and the dashed and dotted curves are the asymptotic
approximations for the small and large varying parameter, respectively. These approximations are defined
in the text immediately below (12).
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Fig. 5 The function f (ω ;u(ω)) defined in (13) is given by the grey curve. The dashed and dotted black
curves are the small and large ω approximations, respectively. These approximations are defined in the
text immediately below (13).
f (ω ;u(ω)) =
(
u+
ω2e−u− e−ωu + 1−ω2
ω(ω− 1)
)
e−u, (13b)
where u(ω)> 0 satisfies
1+ 2ω
ω
+
1+ω
ω(ω − 1)e
−ωu = u+
2ω
ω − 1e
−u. (13c)
The function f is monotonically increasing in ω , and bounded above (figure 5). For
small ω , we find that f ∼ ωu2e−u/4≈ 0.127ω where u satisfies e−u = 1− u+ u2/4
(thus, u ≈ 2.56). For large ω , we find that f ∼ ue−u/2 ≈ 0.162 where u satisfies
e−u = 1− u/2 (thus, u ≈ 1.59). The numerical approximations we give are all to
three significant figures.
From the solutions for the total 3HP produced, (12a), and the maximum value of
malonic semialdehyde, (13), we see that increasing ω will increase both metabolites,
but there is a limiting effect. Increasing ω corresponds to increasing the reaction rate
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through (1c), from aspartate to β -alanine, and thus we can deduce that this reaction
step is important to our goals, but there are diminishing returns.
There is a greater effect on the system from the pre-factor constants λ and β6 =
λ/k¯9 for 3HP and malonic semialdehyde, respectively. λ is a measure of the reaction
rate through (1d), from β -alanine to malonic semialdehyde and L-alanine, and we
can deduce that increasing the flux through this reaction will result in higher levels
of 3HP and malonic semialdehyde. Moreover, a larger value of k¯9 will result in a
lower maximum value of malonic semialdehyde, without affecting the levels of 3HP
at leading order. This physically corresponds to choosing or designing an enzyme to
which malonic semialdehyde will bind very quickly in the reaction (1f) from malonic
semialdehyde to 3HP. Moreover, we see that increasing λ , and hence increasing the
reaction rate through (1d), increases the levels of both 3HP andmalonic semialdehyde
without diminishing returns. Thus, (1d) is an important reaction in the system with
regards to our goal, and the extra malonic semialdehyde produced by higher reaction
rates through this system could be balanced by increasing k¯9.
The reaction (1e), where L-alanine reacts with AKG to produce pyruvate and
GLU, and vice versa, is important for the long-time production of 3HP. The reversibil-
ity of this reaction means that the initial pyruvate is stored as L-alanine, then is able
to be converted back into pyruvate due to the excess AKG produced by the reaction
(1b), from oxaloacetate and GLU to aspartate and AKG. This process provides more
pyruvate for the important reaction (1d), allowing it to proceed for a longer time. By-
passing the long route to β -alanine from pyruvate is important for this system, as the
pyruvate runs out whilst the levels of β -alanine tend to a finite value. Thus, diverting
pyruvate from producing to reacting with β -alanine will result in a more efficient
system and thus increase the total 3HP produced. This effect manifests in the second
term in (12a), where we find that increasing β5, a measure of the backwards reaction
in (1e), from pyruvate to L-alanine, increases the total 3HP produced for the reasons
stated above. However, as the enzyme ALT used in this reaction also affects the value
of Ω , care must be taken in interpreting this result. In particular, a large value of Ω
will reduce the amount of 3HP produced (figure 4).
With regards to over- or under-expressing enzymes in the system, we can use ta-
ble 2 to determine that ω ∼ a1, λ ∼ a2, β5 ∼ a4, β6 ∼ a2/a3, and Ω ∼ a4, where
a1, a2, a3, and a4 relate to the initial concentrations of the enzymes PAND, BAPAT,
HPDH, and ALT, respectively, in the system. Hence, using the arguments presented
above, we may also deduce the following results for enzyme expression (a schematic
of these results is given in figure 6). Over-expressing PAND will monotonically in-
crease the levels of both 3HP and the maximum malonic semialdehyde present, but
the effect of this over-expression has diminishing returns and is bounded above. Sim-
ilarly, over-expressing BAPAT will also result in higher levels of both 3HP and the
maximum malonic semialdehyde present, but now without diminishing returns, as
both scale linearly with a2. Over-expressing HPDH decreases the maximum level of
malonic semialdehyde present (scaling with 1/a3), but has no leading-order effect on
the levels on 3HP. Finally, over-expressingALT will increase the amount of 3HP pro-
duced (scaling with
√
a4 for large a4), without affecting the maximum (leading-order)
level of malonic semialdehyde present. Thus, the effect of over-expressing ALT does
have diminishing returns, but is not bounded above.
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Fig. 6 A schematic to highlight the effect of over-expressing a given enzyme in the no replenishment case
on (a) malonic semialdehyde and (b) 3HP. The underlying network and the arrows between the nodes are
explained in figure 1. An enzyme that is boxed and red/green means that over-expressing this enzyme
causes a/an decrease/increase in the metabolite of interest. Our goal is to reduce the levels of malonic
semialdehyde whilst increasing the levels of 3HP, where possible. A dashed box denotes that the over-
expression has diminishing returns with no upper bound, and a dotted box denotes that the over-expression
has diminishing returns with an upper bound.
4 Continuously replenished pyruvate
4.1 Numerical results
We now investigate the system (4b–m), setting S1 ≡ 1. Thus, the concentration of
pyruvate is no longer governed by (4a). This models a system where pyruvate is being
constantly replenished and maintained at a given value. Solving this system numeri-
cally, we see that there are two main timescales, where t = O(1) and t = O(1/ε1/2)
(recalling that ε = 10−2), respectively (figure 7). In the t = O(1) timescale, the lev-
els of both malonic semialdehyde and 3HP are increasing, before the t = O(1/ε1/2)
timescale, where the levels of malonic semialdehyde increases at a much slower rate,
and the levels of 3HP tends to a constant production rate. There is a further timescale
when t =O(1/ε), and the levels of malonic semialdehyde slightly increase to a steady
state in this timescale.
As with the never-replenished pyruvate case, the levels of malonic semialdehyde
and 3HP can vary significantly when different enzymes are over-expressed.We show
a schematic for the metabolic network in figure 1. Increasing the initial amount of
PAND has no discernible effect on the levels of both malonic semialdehyde and 3HP.
In contrast, over-expressing BAPAT significantly increases the levels of both malonic
semialdehyde and 3HP. We see that over-expressing HPDH does not appear to have
any effect on the levels of 3HP and, in fact, significantly decreases the maximum
amount of malonic semialdehyde in the system. Finally, we see that over-expressing
ALT has a small positive effect on the levels of malonic semialdehyde overall (though
a small negative effect over t = O(101)), and a small negative effect on the levels of
3HP.
We proceed in the same manner as §3, using an asymptotic analysis to explore
the system (4b–m), setting S1 ≡ 1. This will allow us to determine how the system
depends on the dimensionless parameters, and thus to explore the experimental pa-
rameter space without resorting to computationally expensive parameter sweeps.
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Fig. 7 Numerical solutions in the continuously replenished pyruvate case for the dynamic concentrations
of (a) malonic semialdehyde and (b) 3HP. We use the parameter values given in table 2 for all simulations,
and initial dimensionless enzyme concentrations of 1 unless specified in the legend. The solid black line
corresponds to the reference simulation where ai = 1 for i = 1,2,3,4.
4.2 Asymptotic structure
As we did with §3, we now consider this system by exploiting the small parameter, ε ,
and using an asymptotic analysis. There are two main asymptotic regions of interest
in time, where t = O(1) and t = O(1/ε1/2), and we refer to these as medium and
intermediate time, respectively (figure 7).
When t = O(1), the system is governed by the release of pyruvate through the
main pathway to 3HP and towards the production of L-alanine. There is a signifi-
cant increase in the levels of all metabolites apart from pyruvate and GLU, the only
metabolites that are initially present. When t = O(1/ε1/2), the initial rate of metabo-
lite production is slowed and most metabolites approach their steady state. There is a
further asymptotic region when t = O(1/ε), and the system responds to the overpro-
duction of L-alanine due to the continuous replenishment of pyruvate. We consider
this region in an Appendix, as 3HP production is not affected by this redistribution.
In the next section, we solve the leading-order versions of the system (4b–m), with
S1 ≡ 1 in these asymptotic regions.
4.3 Asymptotic solutions
The early-time behaviour of the system is the same as for the never-replenished case,
and this is given in Appendix A. The more interesting behaviour for malonic semi-
aldehyde and 3HP production occurs over longer timescales, which we now discuss
in turn.
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4.3.1 Medium time: t = O(1)
The leading-order system (4b–m), with S1 ≡ 1, as ε → 0 is given by the differential-
algebraic system
S˙2 = 1, S˙3 = k¯2S2R1− k¯4C1, S˙4 = k¯4C1, S˙5 = k¯−7C4, R˙1 = 0,
R˙2 = k¯2S2R1+ k¯−7C4, P˙ = k¯10C3, (14a)
k¯9S6 = k¯6C2, k¯−3C1 = k¯3S3, k¯−5C2 = k¯5S1S4, k¯10C3 = k¯9S6,(
k¯−7+ k¯8
)
C4 = k¯−8S1R1, (14b)
on using (5). The solution to (14) is
S2 = t, (15a)
S3 =
β3
ω
(
e−ωt − 1+ωt), (15b)
S4 =
β4
ω2
(
1−ωt+ ω
2t2
2
− e−ωt
)
, (15c)
S5 = β5t, (15d)
S6 =
β6
ω2
(
1−ωt+ ω
2t2
2
− e−ωt
)
, (15e)
R1 = α, (15f)
R2 = β4
t2
2
+β5t, (15g)
C1 =
γ1
ω
(
e−ωt − 1+ωt), (15h)
C2 =
γ2
ω2
(
1−ωt+ ω
2t2
2
− e−ωt
)
, (15i)
C3 =
γ3
ω2
(
1−ωt+ ω
2t2
2
− e−ωt
)
, (15j)
C4 = γ4, (15k)
P =
λ
ω3
(
e−ωt − 1+ωt− ω
2t2
2
+
ω3t3
6
)
, (15l)
where the parameters are defined in (8). The solutions (15) show excellent agreement
with the numerical results (dashed lines in figure 8). As with the case considered in
§3, we did not have to impose all of the initial conditions to determine (15). That is,
there is an early-time solution as t → 0+. For early time, the diminishing pyruvate
case considered in the previous section is equivalent to the constant pyruvate case we
consider here. Thus, the early-time behaviour for this case is also given in Appendix
A and shows excellent agreement with the numerical results (dashed-dotted lines for
early time in figure 8).
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Fig. 8 The numerical and asymptotic solutions for the metabolite concentrations in the continuously-
replenished pyruvate case. The solid light lines denote the numerical solutions, and the broken darker lines
denote the asymptotic solutions. Dash-dotted lines for t < 10−3 represent the early-time solutions given in
Appendix A (not shown in (a)), dashed lines represent the t = O(1) solutions given in (15), dotted lines
represent the intermediate-time solutions given in (18), and dash-dotted lines for t > 101 represent the
late-time solutions given in (B7) (not shown for (c), (d)). We use parameter values α = 0.5, a1 = 1, a2 = 1,
a3 = 1, and a4 = 1. We have split the metabolite concentrations into (a) metabolites whose early-time
behaviour is described by the t = O(1) behaviour, (b) metabolites whose late-time behaviour is described
by the intermediate-time behaviour, (c) metabolites whose behaviour is distinct in each asymptotic region
we have discussed, and (d) the product. We plot ([Si], [Ri], [Ci ], [P])/S0 .
4.3.2 Intermediate time: t = O(1/ε1/2)
We can see that several terms in the system are promoted to leading order when t =
O(ε−1/2). Using t = τ/ε1/2 with the scalings (S2,S3,S5,C1) = (Sˆ2, Sˆ3, Sˆ5,Cˆ1)/ε1/2,
(S4,S6,R2,C2,C3) = (Sˆ4, Sˆ6, Rˆ2,Cˆ2,Cˆ3)/ε , and P = Pˆ/ε
3/2, where all the new vari-
ables are O(1), the medium-time system (4) becomes
dSˆ2
dτ
= 1− ε1/2k¯2Sˆ2R1, (16a)
ε3/2
dSˆ3
dτ
= ε k¯2Sˆ2R1− k¯3Sˆ3
(
1− ε1/2Cˆ1
)
+ k¯−3Cˆ1, (16b)
dSˆ4
dτ
= k¯4Cˆ1− ε1/2k¯5Sˆ4
(
1− ε2Cˆ2
)
+ ε1/2k¯−5Cˆ2, (16c)
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dSˆ5
dτ
= ε k¯6Cˆ2− ε1/2k¯7Sˆ5Rˆ2
(
1− ε2C4
)
+ k¯−7C4, (16d)
ε3/2
dSˆ6
dτ
= k¯6Cˆ2− k¯9Sˆ6
(
1− ε3Cˆ3
)
+ ε k¯−9Cˆ3, (16e)
dR1
dτ
=−k¯2Sˆ2R1+ ε1/2k¯8C4− ε1/2k¯−8R1
(
1− ε2C4
)
, (16f)
dRˆ2
dτ
= k¯2Sˆ2R1− ε k¯7Sˆ5Rˆ2
(
1− ε2C4
)
+ ε1/2k¯−7C4, (16g)
ε5/2
dCˆ1
dτ
= k¯3Sˆ3
(
1− ε1/2Cˆ1
)
− k¯−3Cˆ1− ε k¯4Cˆ1, (16h)
ε5/2a2
dCˆ2
dτ
= k¯5Sˆ4
(
1− ε2Cˆ2
)− k¯−5Cˆ2− ε k¯6Cˆ2, (16i)
ε5/2a3
dCˆ3
dτ
= k¯9Sˆ6
(
1− ε3Cˆ3
)− ε k¯−9Cˆ3− k¯10Cˆ3, (16j)
ε5/2a4
dC4
dτ
= ε1/2k¯7Sˆ5Rˆ2
(
1− ε2C4
)− k¯−7C4− k¯8C4+ k¯−8R1 (1− ε2C4) , (16k)
dPˆ
dτ
= k¯10Cˆ3, (16l)
and (5) becomes
ε1/2
dSˆ3
dτ
+ ε3/2
dCˆ1
dτ
= k¯2Sˆ2R1− k¯4Cˆ1. (16m)
The leading-order version of (16) is given by the differential-algebraic system
dSˆ2
dτ
= 1,
dSˆ4
dτ
= k¯4Cˆ1,
dSˆ5
dτ
= k¯−7C4,
dR1
dτ
=−k¯2Sˆ2R1, dRˆ2
dτ
= k¯2Sˆ2R1,
dPˆ
dτ
= k¯10Cˆ3, (17a)
k¯3Sˆ3 = k¯−3Cˆ1, k¯9Sˆ6 = k¯6Cˆ2, k¯4Cˆ1 = k¯2Sˆ2R1, k¯−5Cˆ2 = k¯5Sˆ4,(
k¯−7+ k¯8
)
C4 = k¯−8R1, (17b)
and is solved by
Sˆ2 = τ, (18a)
Sˆ3 = β3τe
−k¯2τ2/2, (18b)
Sˆ4 = α
(
1− e−k¯2τ2/2
)
, (18c)
Sˆ5 = β5
√
pi
2k¯2
erf
(
τ
√
k¯2
2
)
, (18d)
Sˆ6 =
β6
k¯2
(
1− e−k¯2τ2/2
)
, (18e)
R1 = αe
−k¯2τ2/2, (18f)
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Rˆ2 = α
(
1− e−k¯2τ2/2
)
, (18g)
Cˆ1 = γ1τe
−k¯2τ2/2, (18h)
Cˆ2 =
γ2
k¯2
(
1− e−k¯2τ2/2
)
, (18i)
Cˆ3 =
γ3
k¯2
(
1− e−k¯2τ2/2
)
, (18j)
C4 = γ4e
−k¯2τ2/2, (18k)
Pˆ =
λ
k¯2
(
τ −
√
pi
2k¯2
erf
(
τ
√
k¯2
2
))
, (18l)
where the error function erf(z) is defined as
erf(z) =
2√
pi
∫ z
0
e−s
2
ds. (19)
These solutions show excellent agreement with the numerical results (dotted lines in
figure 8).
Similarly to the analysis in §3, there is further long-time behaviour arising from
higher-order terms becoming important as lower-order terms exponentially decrease.
These can be obtained by proceeding to higher orders in the above analysis, but it
is simpler to investigate the asymptotic balances in (16) using the solutions (18). As
this does not affect the 3HP production at leading order, we discuss this in Appendix
B.2.
4.4 Discussion
We discuss our results in the same context as for the previous section. That is, we
consider the effect of varying parameters from the heterologous reactions (1c–f), and
with the goal of maximizing 3HP production whilst minimizing the maximum level
of malonic semialdehyde, S6.
We see from the long-time solution (18l) that 3HP ends up being produced at
a constant rate λ/k¯2, and hence the concentration of 3HP ends up linearly increas-
ing with time. Additionally, from (18e), the concentration of malonic semialdehyde
monotonically increases and tends to a constant value of β6/k¯2 = λ/(k¯2k¯9). Hence,
although there are clear differences in the long-time behaviour of this system com-
pared to the never-replenished pyruvate case, there is a similar reaction dependence
between systems. Specifically, whilst increasing the reaction rate through (1d), from
β -alanine to malonic semialdehyde and L-alanine, will result in greater levels of 3HP
and malonic semialdehyde, the levels of malonic semialdehyde produced can be re-
duced by increasing k¯9. That is, by selecting an enzyme to which malonic semialde-
hyde has a large binding affinity.
In contrast to the never-replenished pyruvate case, the continuously-replenished
pyruvate case has no leading-order dependence on (1c), the reaction from aspartate
to β -alanine, nor on (1e), the reaction where L-alanine reacts with AKG to produce
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Pyruvate ([S1])
Oxaloacetate ([S2]) Aspartate ([S3])
β-alanine ([S4])
L-alanine ([S5]) Malonic semialdehyde ([S6])
3HP ([P ])
PAND ([E1])
BAPAT ([E2])
HPDH ([E3])
ALT ([E4])
(a)
Pyruvate ([S1])
Oxaloacetate ([S2]) Aspartate ([S3])
β-alanine ([S4])
L-alanine ([S5]) Malonic semialdehyde ([S6])
3HP ([P ])
PAND ([E1])
BAPAT ([E2])
HPDH ([E3])
ALT ([E4])
(b)
Fig. 9 A schematic to highlight the effect of over-expressing a given enzyme in the continuous replen-
ishment case on (a) malonic semialdehyde and (b) 3HP. The underlying network and the arrows between
the nodes are explained in figure 1. An enzyme that is boxed and red/green means that over-expressing
this enzyme causes a/an decrease/increase in the metabolite of interest. Our goal is to reduce the levels of
malonic semialdehyde whilst increasing the levels of 3HP, where possible.
pyruvate and GLU, and vice versa. Increasing the flux through the former and the
reverse reaction of the latter had a positive effect on 3HP production, where the latter
allowed L-alanine to initially act as a pyruvate store, before releasing pyruvate to
react with β -alanine. Thus, for long-time, the rate of 3HP production and the levels
of malonic semialdehyde are only dependent on the reaction (1d), compared to §3
where these quantities are dependent on (1c–e).
With regards to over- or under-expressing enzymes in the system, we can use table
2 to determine that λ ∼ a2 and k¯9 ∼ a3, where a2 and a3 relate to the initial concen-
trations of the enzymes BAPAT and HPDH, respectively, in the system (a schematic
of these results is given in figure 9). Hence, using the arguments presented above,
we may also deduce that over-expressing BAPAT will result in higher levels of both
3HP and the maximum malonic semialdehyde present, both scaling linearly with a2.
However, over-expressingHPDH decreases the maximum level of malonic semialde-
hyde present, which is inversely proportional to a3, but has no leading-order effect on
the levels on 3HP. Importantly, we also find that, in contrast to the non-replenished-
pyruvate case, there is no leading-order dependence on the initial concentrations of
PAND or ALT. Thus, our model suggests that the over-expression of PAND or ALT
will not result in significant differences in the maximum level of malonic semialde-
hyde or the 3HP production for continuous replenishment of pyruvate.
5 Conclusions
In this paper, we develop and solve a mathematical model for 3-hydroxypropionic
acid (3HP) production from pyruvate via aspartate and β -alanine. We consider two
limiting cases, where the initial level of pyruvate is never and continuously replen-
ished, respectively. In both cases, we make substantial asymptotic progress to gain
physical insight into the system behaviour, successfully comparing these results with
numerical solutions to check their accuracy. Our asymptotic model (including rela-
tively straightforward explicit expressions) allows us to predict and quantify ways to
increase the levels of 3HP produced without increasing the levels of malonic semi-
aldehyde, a toxic compound produced as an intermediate in the pathway.
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Fig. 10 (a) The maximum level of malonic semialdehyde in the system, (b) the total 3HP produced, both in
the no replenishment of pyruvate case. In both figures, the labels on the x-axis denote (i) Reference value
(using the initial enzyme concentrations a1 = a2 = a3 = a4 = 1). (ii) Over-expressing PAND (a1 = 10,
a2 = a3 = a4 = 1), (iii) Concurrently over-expressing BAPAT and HPDH (a1 = a4 = 1, a2 = a3 = 10), (iv)
Over-expressing ALT (a1 = a2 = a3 = 1, a4 = 10). The units of the y-axis are mM.
In terms of over-expressing enzymes, we find that for both cases the strongest
positive effect comes from simultaneously over-expressing both BAPAT and HPDH.
This significantly increase the levels of 3HP produced, but provides no significant in-
crease in the maximummalonic semialdehyde present ((iii) in figures 10 and 11). Our
results also show that over-expressing just one of BAPAT or HPDH will not have as
strong an effect. We see a similar (though weaker) effect when over-expressing ALT
for a limited supply of pyruvate, and the maximum level of malonic semialdehyde
is slightly reduced ((iv) in figure 10). However, when pyruvate is continuously re-
plenished, over-expressing ALT leads to a small increase in both the maximum level
of malonic semialdehyde and the rate of 3HP production ((iv) in figure 11). Finally,
over-expressing PAND only has a significant effect when there is a limited supply
of pyruvate, where the over-expression leads to a slight increase in the maximum
level of malonic semialdehyde present ((ii) in figure 10). This effect vanishes when
the pyruvate is continuously replenished ((ii) in figure 11). We provide schematics
outlining the effect of over-expressing a given enzyme on both malonic semialde-
hyde and 3HP in figures 6 and 9 for the never and continuous replenishment cases,
respectively.
Another approach to optimizing metabolite pathways is to explore alternative en-
zymes for a given reaction. Our results can also be used to expedite this process, as
we are able to determine how the system behaves as a function of the kinetic parame-
ters of the enzymes, which will differ for alternative enzymes. Thus, we may interpret
our results to determine the optimal targets for enzyme replacement. We find that, in
both cases, the kinetic parameters involving the enzyme BAPAT (k¯5, k¯−5, and k¯6, de-
fined in table 2) have the most significant effect on 3HP production, and our model
suggests that focusing attention on maximizing the parameter grouping k¯5k¯6/k¯−5 will
have the greatest effect on 3HP yield. Although increasing k¯5k¯6/k¯−5 also has the ef-
fect of increasing the levels of malonic semialdehyde, we further show that choosing
an HPDH enzyme to which malonic semialdehyde will quickly bind can negate this
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Fig. 11 (a) The maximum level of malonic semialdehyde in the system, (b) the eventual rate of 3HP
production, both in the continuous replenishment of pyruvate case. In (b), we use P/t as the label for the
y-axis as the levels of 3HP linearly increase with time (this continuous production is due to the continuous
replenishment of pyruvate), and thus the appropriate measure here is the long-time production rate of 3HP.
In both figures, the labels on the x-axis denote (i) Reference value (using the initial enzyme concentrations
a1 = a2 = a3 = a4 = 1). (ii) Over-expressing PAND (a1 = 10, a2 = a3 = a4 = 1), (iii) Concurrently over-
expressing BAPAT and HPDH (a1 = a4 = 1, a2 = a3 = 10), (iv) Over-expressing ALT (a1 = a2 = a3 = 1,
a4 = 10). The units of the y-axis are mM.
issue (that is, increasing k¯9, defined in table 2), and we show in figures 10 and 11 that
this combined effect of increasing the 3HP production whilst maintaining the maxi-
mum level of malonic semialdehyde can also be achieved by over-expressing BAPAT
and HPDH.
We additionally show that the kinetic parameters involving the enzyme ALT (k¯7,
k¯−7, k¯8, and k¯−8, defined in table 2) have a leading-order effect on the 3HP levels
when the initial level of pyruvate is never replenished. This is because the reversibility
of the reaction effectively allows pyruvate to be stored and converted back when
required. This storage effect is negligible in the continuous replenishment case as the
pyruvate is plentiful (by definition) and thus there is no benefit to having additional
storage of pyruvate. The important parameter groupings here are k¯7k¯8/(k¯−7 + k¯8)
and k¯−7k¯−8/(k¯7k¯8), where increasing both of these dimensionless groupings leads to
more 3HP produced, with no effect on the maximum levels of malonic semialdehyde
present at leading order. We find that the combined effect of these parameters means
that k¯−7 and k¯−8 should be increased, whereas k¯7 and k¯8 should be decreased, and we
note that there are diminishing returns on increasing k¯−7. We show in figure 10 that
this effect can be weakly obtained by over-expressing ALT.
The kinetic parameters of the remaining enzyme we consider, PAND, given by
k¯3, k¯−3, and k¯4 defined in table 2, are only significant at leading order in the never-
replenished pyruvate case. In this case, we find that increasing the value of the pa-
rameter grouping k¯3k¯4/k¯−3 increases both the amount of 3HP produced, and also the
maximum levels of malonic semialdehyde present. However, the effect of increasing
this parameter grouping is bounded above, and thus these diminishing returns sug-
gest that this parameter grouping is unlikely to be particularly useful to exploit for
the eventual goal of industrial production of 3HP.
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We show that, although the full reaction dynamics are different between the never-
replenished and continuously-replenished pyruvate cases, there are general similari-
ties between predictions of the important reactions in both cases. Namely, our model
suggests that over-expressing BAPAT or using a version of BAPAT with different
kinetic parameters will increase levels of both 3HP and malonic semialdehyde, and
that over-expressing HPDH or using an alternate that can very quickly bind to mal-
onic semialdehyde will decrease the levels of malonic semialdehyde. The main dif-
ferences between the two cases are as follows. Firstly, the kinetic parameters in-
volved in the PAND and ALT reactions have a leading-order effect in the never-
replenished pyruvate case, but not in the continuously-replenished case. Secondly,
the time taken to reach the ‘long-time’ stage of 3HP production is asymptotically
larger in the continuously-replenished pyruvate case, an effect relating to the contin-
uous production of 3HP in this case. Thirdly, the malonic semialdehyde reaches its
maximum value at a finite time in the never-replenished case, but tends to its maxi-
mum (constant) value in the continuously-replenished case.
We have made significant use of asymptotic analysis in this paper. This method
has allowed us to determine the key parameter groupings involved in the produc-
tion of 3HP and malonic semialdehyde. Moreover, there are some interesting aspects
of the asymptotic analysis in its own right. For example, we have leading-order ex-
ponentially decreasing terms that become subdominant to algebraically increasing
terms. Resolving this issue without going to higher asymptotic orders requires match-
ing over a timescale that involves logarithmic functions of the small parameter ε , as
shown in Appendix B.1. Another interesting facet of the asymptotic analysis we per-
form is that, in the never-replenished pyruvate case, there are effects that occur over
two asymptotic timescales that contribute to the levels of 3HP at leading order, and
the system behaviour over the longer timescale highlights how L-alanine acts as a
store for pyruvate, yielding deeper physical insight into the system.
The two limiting cases of pyruvate replenishment that we have considered in this
paper are chosen as modelling assumptions. In reality, the levels of pyruvate will fall
somewhere between these two extremes, as some time-dependent level of pyruvate
will be generated from glucose via glycolysis. Whilst our model does highlight the
BAPAT enzyme as the most important to 3HP production in both of the extreme cases
we consider, it may be interesting to investigate whether this is true for any given
pyruvate production. This could be examined by imposing a certain time-dependent
form for the pyruvate concentration (as we did by imposing that pyruvate was con-
stant in the second case we considered) if it were known, or by including a known
source of pyruvate in the governing equations and solving the full system. From (4),
the governing equations for O(1) time, we can see that the leading-order metabolite
concentrations can be written in terms of integrals of (time-dependent) imposed pyru-
vate concentrations or pyruvate sources, and these are given in Appendix C. It may
be instructive to analysis these general results further.
Additionally, we chose somewhat arbitrary initial conditions which modelled the
instantaneous addition of pyruvate to a well-mixed solution of enzymes. In reality,
there is no clean starting point to such a set of reactions and there are likely to be small
initial levels of every metabolite. We have tested our results for small but non-zero
initial values of each metabolite and found that the early-time solutions we derived in
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Appendix A were inaccurate, but that the system relaxed into the remaining solutions
we derived in this paper (results not shown).
Care must be taken with applying these results to in vivo experiments. Some of
the metabolite concentrations we have derived are very small and, whilst this is not
an issue for reactions occurring within a well-mixed beaker in vitro, it may pose a
problem if the situation being modelled is reactions occurring within cells. For one
molecule within a cell, the resulting macroscale concentration within a bacteria cell
would be roughly 10−9M ≈ ε3S0 using the typical parameter values in this paper.
Hence, care needs to be taken when interpreting our results for reactions occurring
within bacterial cells. One option to accurately model a small number of molecules is
is to perform stochastic simulations of the molecule numbers, assigning a probability
of each reaction occurring. Additionally, for small numbers of molecules it may be
that spatial effects are important. It would be useful to include these extra features in
an extension of this work to check whether our conclusions still applied for in vivo
experiments, but we note that this would significantly increase the computational
expense of solving the model.
Finally, we note that this work highlights how mathematical models can be used
to understand a complicated system, even one exhibiting nonlinear behaviour. From
our model, we were able to highlight the strong positive effect of over-expressing
two enzymes, BAPAT and HPDH, at the same time to increase 3HP production while
maintaining the levels of malonic semialdehyde. Such theoretical results should allow
significant reductions in the time taken to explore the experimental parameter space,
and to aid in other ways the understanding of biological systems.
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Appendix A Early-time solution
By Taylor expanding the system (4) around the initial conditions, we can deduce the leading-order be-
haviour
S1 ∼ 1, S2 ∼ t, S3 ∼ α k¯2 t
2
2!
, S4 ∼ α k¯2k¯3k¯4
ε2
t4
4!
, S5 ∼ α k¯−7k¯−8
a4ε2
t2
2!
, S6 ∼ α k¯2k¯3 k¯4k¯5 k¯6
a2ε5
t6
6!
,
R1 ∼ α , R2 ∼ α k¯−7k¯−8
a4ε2
t2
2!
,
C1 ∼ α k¯2k¯3
ε2
t3
3!
, C2 ∼ α k¯2k¯3 k¯4k¯5
a2ε4
t5
5!
, C3 ∼ α k¯2k¯3k¯4 k¯5 k¯6k¯9
a2a3ε7
t7
7!
, C4 ∼ α k¯−8
a4ε2
t,
P ∼ α k¯2k¯3 k¯4k¯5 k¯6k¯9 k¯10
a2a3ε7
t8
8!
,
as t → 0+. These results are expansions in which t, rather than ε , is the small parameter, and yield the
earliest behaviour of the system. In figures 3 and 8, we see that these asymptotic solutions agree very well
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Fig. 12 (a) The shaded areas denote the regions in which there is switching of asymptotic orders in the
long-time solution for limited initial pyruvate. In the region where Ω < 1/α − 1, solutions (B2) hold. In
the region where Ω < α − 1, solutions (B4) hold. (b) Results for S3, taking ki = a j = 1 for all i, j, and
α = 0.5, thus falling into the region where α < 1 and Ω < 1/α − 1. The solid grey curve shows the
numerical result, the dashed black curve shows the O(1) term in (B2a), and the dotted black curve shows
the full expression given in (B2a). The latter two asymptotic results show excellent agreement with the
numerical result until t ≈ 103 , where asymptotic switching occurs, and the O(ε) term in (B2a) dominates.
with the numerical solutions at early time. We note that these early-time solutions will be sensitive to any
change in initial conditions.
Appendix B Long-time behaviour
In the main text, we have given the long-time behaviour of the system for times up to the asymptotic orders
at which the levels of 3HP are affected. There is further interesting transient behaviour for the rest of the
system and, in this Appendix, we discuss this behaviour.
Appendix B.1 Never-replenished pyruvate
There is further long-time behaviour that can occur for the never-replenished pyruvate case which phys-
ically corresponds to a slower decay of metabolites than predicted in the main text. We see from the
long-time solutions (11) that the metabolites that decay have decay rates of |1−α | or min(Ω ,αΩ ). Thus,
if higher order terms have slower decay rates than lower order terms in the long-time system (9), the
asymptotic order of terms will eventually switch. We find that asymptotic switching occurs for α < 1 if
and only if Ω < 1/α −1, and for α > 1 if and only if Ω < α−1 (figure 12a).
When α < 1 and Ω < 1/α −1, we look into the region in (9) where
T − log(1/ε)
k¯2(1−α−αΩ )
= O(1), (B1)
to determine the leading-order corrections
S3 ∼ β3(1−α)2ek¯2(α−1)T + ε β4β5Ω k¯8
ω(1−α)Ω−1(1−α −αΩ )e
−α k¯2ΩT , (B2a)
R1 ∼ α(1−α)ek¯2(α−1)T + ε β4β5Ω k¯8
k¯2(1−α)Ω (1−α −αΩ )
e−α k¯2ΩT , (B2b)
C1 ∼ γ1(1−α)2ek¯2(α−1)T + ε β4β5Ω k¯8
k¯4(1−α)Ω−1(1−α −αΩ )
e−α k¯2ΩT , (B2c)
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as T → ∞. The O(ε) terms in (B2) arise because the O(1) term has a larger exponential decay rate than
the O(ε) term in (9g), and thus these terms will eventually balance. When α > 1 and Ω < α −1, we look
into the region in (9) where
T − log(1/ε)
k¯2(α−1−Ω )
= O(1), (B3)
to determine the leading-order corrections
S2 ∼ α −1
α
ek¯2(1−α)T + ε
(
α
α −1
)Ω β5Ω
(α −1−Ω ) e
−k¯2ΩT , (B4a)
S3 ∼ β3
(
α −1
α
)2
ek¯2(1−α)T + ε
(
α
α −1
)Ω−1 β4β5Ω
ω(α−1−Ω ) e
−k¯2ΩT , (B4b)
C1 ∼ γ1
(
α−1
α
)2
ek¯2(1−α)T + ε
(
α
α −1
)Ω−1 β4β5Ω
k¯4(α −1−Ω )
e−k¯2ΩT , (B4c)
as T →∞. The O(ε) terms in (B4) arise because the O(1) term has a larger exponential decay rate than the
O(ε) term in (9b), and thus these terms will eventually balance. We see that these solutions are excellent
approximations to the numerical solution.
This further long-time behaviour occurs when (1e), the reaction between L-alanine and pyruvate, is
slow. The physical interpretation of the solutions in this appendix is that this slow reaction allows a slow
replenishment of pyruvate which, in turn, is converted through the metabolites in the pathway to β -alanine.
This slow release allows for a more gradual depletion of these intermediates.
Appendix B.2 Continuously-replenished pyruvate
There is further long-time behaviour that can occur for the continuously-replenished pyruvate case which
physically corresponds to some metabolites reaching a steady state rather than vanishing as predicted in the
main text. Using τ = T/ε1/2 (and hence t = T/ε) with the scalings (Sˆ2, Pˆ) = ε
−1/2(S˜2, P˜), Cˆ4 = ε1/2C˜4 ,
(Sˆ3,Cˆ1) = ε(S˜3,C˜1), and R1 = ε
3/2R˜1, where all the new variables are O(1), the long-time system (16)
becomes
dS˜2
dT
= 1− ε3/2k¯2 S˜2R˜1, (B5a)
ε2
dS˜3
dT
= ε k¯2S˜2R˜1− k¯3S˜3
(
1− ε3/2C˜1
)
+ k¯−3C˜1, (B5b)
dSˆ4
dT
= ε1/2k¯4C˜1− k¯5Sˆ4
(
1− ε2Cˆ2
)
+ k¯−5Cˆ2, (B5c)
dSˆ5
dT
= ε1/2k¯6Cˆ2− k¯7S˜5Rˆ2
(
1− ε5/2C˜4
)
+ k¯−7C˜4, (B5d)
ε2
dSˆ6
dT
= k¯6Cˆ2− k¯9 Sˆ6
(
1− ε3Cˆ3
)
+ ε k¯−9Cˆ3, (B5e)
ε
dR˜1
dT
=−k¯2S˜2R˜1+ k¯8C˜4− ε k¯−8R˜1
(
1− ε5/2C˜4
)
, (B5f)
dRˆ2
dT
= ε1/2k¯2S˜2R˜1− ε1/2k¯7S˜5Rˆ2
(
1− ε5/2C˜4
)
+ ε1/2k¯−7C˜4, (B5g)
ε3
dC˜1
dT
= k¯3 S˜3
(
1− ε3/2C˜1
)
− k¯−3C˜1− ε k¯4C˜1, (B5h)
ε3a2
dCˆ2
dT
= k¯5 Sˆ4
(
1− ε2Cˆ2
)− k¯−5Cˆ2− ε k¯6Cˆ2, (B5i)
ε3a3
dCˆ3
dT
= k¯9 Sˆ6
(
1− ε3Cˆ3
)− ε k¯−9Cˆ3− k¯10Cˆ3, (B5j)
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ε3a4
dC˜4
dT
= k¯7 Sˆ5Rˆ2
(
1− ε5/2C˜4
)
− k¯−7C˜4− k¯8C˜4+ ε k¯−8R˜1
(
1− ε5/2C˜4
)
, (B5k)
dP˜
dT
= k¯10Cˆ3. (B5l)
To fully explain the long-term behaviour is it useful to consider some of the solutions up to O(ε1/2). Hence,
we give (B5) up to O(ε1/2), resulting in the following differential-algebraic system
dS˜2
dT
= 1,
dSˆ4
dT
= ε1/2k¯4C˜1− k¯5 Sˆ4+ k¯−5Cˆ2, dSˆ5
dT
= ε1/2k¯6Cˆ2− k¯7S˜5Rˆ2+ k¯−7C˜4,
dRˆ2
dT
= ε1/2k¯2 S˜2R˜1− ε1/2k¯7 S˜5Rˆ2+ ε1/2k¯−7C˜4, dP˜
dT
= k¯10Cˆ3, (B6a)
k¯3 S˜3 = k¯−3C˜1, k¯9Sˆ6 = k¯6Cˆ2, k¯2S˜2R˜1 = k¯8C˜4, k¯4C˜1 = k¯2S˜2R˜1, k¯−5Cˆ2 = k¯5Sˆ4,
k¯10Cˆ3 = k¯9Sˆ6,
(
k¯−7+ k¯8
)
C˜4 = k¯7Sˆ5Rˆ2, (B6b)
on using (5) with the scalings introduced in this section.
The solution to (B6) is
S˜2 = T, (B7a)
S˜3 =
1
ω
((
β4λΩ
√
pi
2k¯2
− ε1/2 λ
k¯2
)
e−β4ΩT + ε1/2
λ
k¯2
)
, (B7b)
Sˆ4 = α , (B7c)
S˜5 =
1
β4Ω
((
β4λΩ
√
pi
2k¯2
− ε1/2 λ
k¯2
)
e−β4ΩT + ε1/2
λ
k¯2
)
, (B7d)
Sˆ6 =
β6
k¯2
, (B7e)
R˜1 =
1
k¯2T
((
β4λΩ
√
pi
2k¯2
− ε1/2 λ
k¯2
)
e−β4ΩT + ε1/2
λ
k¯2
)
, (B7f)
Rˆ2 = α , (B7g)
C˜1 =
1
k¯4
((
β4λΩ
√
pi
2k¯2
− ε1/2 λ
k¯2
)
e−β4ΩT + ε1/2
λ
k¯2
)
, (B7h)
Cˆ2 =
γ2
k¯2
, (B7i)
Cˆ3 =
γ3
k¯2
, (B7j)
C˜4 =
1
k¯8
((
β4λΩ
√
pi
2k¯2
− ε1/2 λ
k¯2
)
e−β4ΩT + ε1/2
λ
k¯2
)
, (B7k)
P˜ =
λ
k¯2
T, (B7l)
where we give the solutions up to O(ε1/2) for the metabolites where the O(1) term is exponentially de-
creasing. In these cases, there is a constant O(ε1/2) term, and we wish to avoid introducing a further
boundary layer when T = (1/(2β4Ω )) log(1/ε)+O(1) to switch the asymptotic order of terms. To give
the O(ε1/2) terms for the remaining metabolites, we would need to match with higher order terms from
the t = O(ε−1/2) region which, in turn, we would need to match with higher order terms from the t =O(1)
region. As we are satisfied with our current level of accuracy, we omit this for brevity. The solutions (B7)
show excellent agreement with the numerical results (dash-dotted lines for late time in figure 8).
The long-time behaviour (B7) allows the levels of aspartate and L-alanine to attain their correct steady
state values which are limited by (1d), the BAPAT reaction. The levels of aspartate sharply decrease when
t = O(1/ε1/2) as aspartate is converted into β -alanine which is free to react with all the excess pyruvate in
the system. In (B7), this sharp decrease is balanced by a slow but steady conversion of pyruvate (through
oxaloacetate) into aspartate, allowing for a finite steady state. The levels of L-alanine are artificially high
when t = O(1/ε1/2) due to the reaction of β -alanine with all the excess pyruvate into L-alanine (and
malonic semialdehyde). This large production of L-alanine is balanced in (B7) by the conversion of L-
alanine into pyruvate.
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Appendix C General solutions for t = O(1)
The general problem for t = O(1) is given by (6), ignoring the equation S˙1 = −S1. Instead, S1 is either
imposed to be a specific function of time, or governed by
S˙1 = f (t)−S1, (C1)
at leading order for small ε , where f (t) represents a time-dependent source of pyruvate. In this paper,
we have considered the cases f ≡ 0 and S1 ≡ 1 (equivalent to f ≡ 1 at leading order) in more detail,
corresponding to no replenishment and continuous replenishment of pyruvate, respectively. As (C1) is
solved by
S1 = e
−t +
∫ t
0
es−t f (s)ds, (C2)
we can determine S1(t) in either case. Hence, we give the solution to (6) in terms of a general S1(t)
(ignoring the equation S˙1 =−S1), as follows
S2 =
∫ t
0
S1(s)ds, (C3a)
S3 = β3
∫ t
0
(
1− eω(s−t)
)
S1(s)ds, (C3b)
S4 = β4
∫ t
0
(
t− s+ e
ω(s−t)−1
ω
)
S1(s)ds, (C3c)
S5 = β5
∫ t
0
S1(s)ds, (C3d)
S6 = β6S1(t)
∫ t
0
(
t− s+ e
ω(s−t)−1
ω
)
S1(s)ds, (C3e)
R1 = α , (C3f)
R2 =
∫ t
0
(β4 (t− s)+β5)S1(s)ds, (C3g)
C1 = γ1
∫ t
0
(
1− eω(s−t)
)
S1(s)ds, (C3h)
C2 = γ2S1(t)
∫ t
0
(
t− s+ e
ω(s−t)−1
ω
)
S1(s)ds, (C3i)
C3 = γ3S1(t)
∫ t
0
(
t− s+ e
ω(s−t)−1
ω
)
S1(s)ds, (C3j)
C4 = γ4S1(t), (C3k)
P = λ
∫ t
0
S1(s)
∫ s
0
(
s− v+ e
ω(v−s)−1
ω
)
S1(v)dvds. (C3l)
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